# LG Life Sciences clinical trials: 78 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 78 trials with LG Life Sciences as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by LG Life Sciences: 78 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/lg-life-sciences

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 78
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 78, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 13, 2018 | NCT03738020 | Clinical Study to Evaluate the Correction of Wrinkles and Folds and Safety of YVOIRE Classic Versus Restylane in Nasolabial Fold... | LG Life Sciences | Not applicable | Completed | Temporary Correction of Wrinkles | 58 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03738020) |
| November 13, 2018 | NCT03738007 | Clinical Study to Evaluate the Correction of Facial Wrinkles and Folds and Safety of YVOIRE Volume Versus Perlane in Nasolabial Fold... | LG Life Sciences | Not applicable | Completed | Temporary Correction of Wrinkles | 57 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03738007) |
| February 13, 2017 | NCT03051087 | To Compare and Evaluate the Efficacy and Safety of Ganilever PFS(Prefilled Syringe) and Orgalutran® | LG Life Sciences | Phase 4 | Completed | Controlled Ovarian Stimulation | 255 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03051087) |
| January 10, 2017 | NCT03015909 | Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj. | LG Life Sciences | Phase 4 | Completed | Short Stature, Idiopathic, Infant, Small for Gestational Age, Growth Hormone Deficiency, Chronic Renal Failure, Turner... | 116 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03015909) |
| September 8, 2016 | NCT02892812 | A Phase I Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine and 14-valent Pneumococcal Conjugate Vaccine in Adults | LG Life Sciences | Phase 1 | Completed | Pneumococcal Infections | 63 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02892812) |
| July 13, 2016 | NCT02831361 | Trial to Evaluate the Efficacy and Safety of Gemigliptin Compared With Placebo Added on Insulin Alone or on Insulin in Combination With... | LG Life Sciences | Phase 3 | Completed | Type 2 Diabetes Mellitus | 290 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02831361) |
| May 12, 2016 | NCT02770664 | Study to Evaluate the Efficacy, Safety and PK of Intravenous Single Injection LC28-0126 Immediately Before PCI in STEMI Patients | LG Life Sciences | Phase 2 | Unknown | ST-segment Elevation Myocardial Infarction | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02770664) |
| April 21, 2016 | NCT02746380 | A Study Comparing LBAL to Humira® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy | LG Life Sciences | Phase 3 | Completed | Arthritis, Rheumatoid | 383 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02746380) |
| March 22, 2016 | NCT02715908 | A Study to Evaluate the Long-term Safety and Efficacy of LBEC0101 in Subjects With Active RA Despite Methotrexate (MTX) | LG Life Sciences | Phase 3 | Completed | Rheumatoid Arthritis | 148 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02715908) |
| February 1, 2016 | NCT02670070 | BE Study of the Combinations of Gemigliptin 50mg and Rosuvastatin 20mg in Comparison to Each Component Administered Alone | LG Life Sciences | Phase 1 | Unknown | Healthy | 37 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02670070) |
| February 1, 2016 | NCT02670018 | BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 2000mg in Comparison to Each Component Administered... | LG Life Sciences | Phase 1 | Unknown | Healthy | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02670018) |
| January 22, 2016 | NCT02661737 | Observational Study to Evaluate Long-term Safety and Biodegradability of YVOIRE Volume s | LG Life Sciences | Observational | Completed | Correction of Nasolabial Folds | 503 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02661737) |
| June 1, 2015 | NCT02458768 | Multicenter, Randomized, Open Label, Parallel Study to Evaluate the Efficacy & Safety of IVF-M HP Inj. vs. Menopur® Inj. | LG Life Sciences | Phase 4 | Completed | Infertility, Female | 112 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02458768) |
| May 18, 2015 | NCT02446353 | Pharmacokinetics and Safety Study of Apetrol ES | LG Life Sciences | Phase 1 | Completed | Healthy | 79 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02446353) |
| April 24, 2015 | NCT02426151 | Bioequivalence of a Single Subcutaneous Dose of BEPO and REPO in Healthy Male Subjects | LG Life Sciences | Phase 1 | Completed | Healthy | 46 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02426151) |
| April 14, 2015 | NCT02415192 | Observational Study to Evaluate the Safety and Efficacy for Levacalm Tab. Versus Valsartan/Amlodipine Combination Therapy in Essential... | LG Life Sciences | Observational | Unknown | Lower Leg Edema, Orthostatic Hypertension | 2,001 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02415192) |
| February 6, 2015 | NCT02357069 | A Study Comparing LBEC0101 to Enbrel® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy | LG Life Sciences | Phase 3 | Unknown | Arthritis, Rheumatoid | 372 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02357069) |
| January 16, 2015 | NCT02340091 | A Clinical Study to Evaluate the Efficacy and Safety of YVOIRE Classic Plus Versus YVOIRE Classic in Nasolabial Fold Injection | LG Life Sciences | Not applicable | Completed | Wrinkles | 62 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02340091) |
| January 16, 2015 | NCT02340078 | A Clinical Study to Evaluate the Efficacy and Safety of YVOIRE Volume Plus Versus YVOIRE Volume in Nasolabial Fold Injection | LG Life Sciences | Not applicable | Completed | Wrinkles | 62 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02340078) |
| January 8, 2015 | NCT02334358 | Observational Study to Evaluate Long-term Safety and Biodegradability of YVOIRE Classic s | LG Life Sciences | Observational | Completed | Correction of Nasolabial Folds | 503 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02334358) |
| November 14, 2014 | NCT02290301 | An Observational Study to Evaluate Cardiovascular Outcomes of T2DM PatientsTreated With Gemigliptin | LG Life Sciences | Observational | Completed | Type 2 Diabetes Mellitus | 5,180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02290301) |
| October 6, 2014 | NCT02257645 | Post-authorization Safety Study of Euforvac-Hib Vaccine for Active Primary Immunization in Infants From 6 Weeks | LG Life Sciences | Observational | Unknown | Diphtheria, Tetanus, Pertussis, Hepatitis B, Haemophilus Influenza Type B | 3,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02257645) |
| August 1, 2014 | NCT02206867 | Pharmacokinetics and Safety Study of LBAL in Healthy Subjects | LG Life Sciences | Phase 1 | Completed | Healthy Subjects | 116 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02206867) |
| July 30, 2014 | NCT02204163 | Study to Assess the Efficacy and Safety of Eutropin in Prader-Willi Syndrome | LG Life Sciences | Phase 3 | Completed | Prader-Willi Syndrome | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02204163) |
| April 30, 2014 | NCT02126358 | Gemigliptin-Rosuvastatin Fix-dose Combination Phase 3(BALANCE) | LG Life Sciences | Phase 3 | Completed | Type 2 Diabetes, Dyslipidemia | 290 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02126358) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 28 |
| Phase 1/2 | 1 |
| Phase 2 | 7 |
| Phase 3 | 23 |
| Phase 4 | 8 |
| Not applicable | 6 |
| Observational | 5 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 66 |
| Unknown | 11 |
| Terminated | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Diabetes Mellitus, Type 2 | 10 |
| Dwarfism, Pituitary | 5 |
| Hypertension | 5 |
| Hyperlipidemias | 3 |
| Arthritis, Rheumatoid | 3 |
| Hepatitis B, Chronic | 3 |
| Hepatitis B | 2 |
| Pituitary Diseases | 2 |
| Vomiting | 2 |
| Osteoarthritis, Knee | 2 |
| Communicable Diseases | 2 |
| ST Elevation Myocardial Infarction | 2 |
| Diphtheria | 1 |
| Tetanus | 1 |
| Whooping Cough | 1 |
| Essential Hypertension | 1 |
| Pneumococcal Infections | 1 |
| Renal Insufficiency | 1 |
| Diabetes Mellitus | 1 |
| Urinary Bladder, Overactive | 1 |
| Infections | 1 |
| Influenza, Human | 1 |
| Orthomyxoviridae Infections | 1 |
| RNA Virus Infections | 1 |
| Virus Diseases | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Aircraft parts suppliers in the United States](https://specstream.ai/data/businesses/aircraft-parts-suppliers/united-states)
- [Prenatal and perinatal care clinics in the United States](https://specstream.ai/data/businesses/prenatal-and-perinatal-care-clinics/united-states)
- [Health insurance offices in the United States](https://specstream.ai/data/businesses/health-insurance-offices/united-states)
- [Business consulting firms in the United States](https://specstream.ai/data/businesses/business-consulting-firms/united-states)
- [Syrian restaurants in the United States](https://specstream.ai/data/businesses/syrian-restaurants/united-states)
- [Mediators in the United States](https://specstream.ai/data/businesses/mediators/united-states)
